| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 40 |
| 1 | LAMOTRIGINE | 39 |
| 2 | VALPROATE SODIUM | 38 |
| 3 | RITONAVIR | 37 |
| 4 | ATAZANAVIR | 35 |
| 5 | METHOTREXATE | 35 |
| 6 | LAMOTIRIGINE | 34 |
| 7 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 34 |
| 8 | LAMOTRIGINE EXTENDED-RELEASE | 34 |
| 9 | DARUNAVIR | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CARBONATE | 8 | 0.0342 |
| 1 | ABACAVIR AND LAMIVUDINE | 1 | 0.0050 |
| 2 | NEVIRAPINE | 30 | 0.0033 |
| 3 | MISOPROSTOL | 25 | 0.0026 |
| 4 | ATAZANAVIR | 35 | 0.0024 |
| 5 | PIMOZIDE | 1 | 0.0021 |
| 6 | DARUNAVIR | 30 | 0.0020 |
| 7 | VALPROATE SODIUM | 38 | 0.0018 |
| 8 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 9 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 25 | 0.0015 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0012 |
| 2 | Protease Inhibitor [EPC] | 51 | 0.0011 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 51 | 0.0008 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 23 | 0.0005 |
| 5 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 6 | Antimycobacterial [EPC] | 9 | 0.0004 |
| 7 | Mood Stabilizer [EPC] | 78 | 0.0004 |
| 8 | Anti-epileptic Agent [EPC] | 76 | 0.0003 |
| 9 | Oxytocic [EPC] | 1 | 0.0003 |